Pixels & Pills

Entries Tagged as 'business'

4 Things Pharma Marketing Can Learn from Other Industries

September 2nd, 2010 · No Comments · Opinion, Trends

By Guy Mastrion (@gmastrion)
Across all industries, people are using new technologies, tactics and communication mediums to connect with customers and accelerate business momentum. What qualities do other industries possess that can be beneficial to pharma?
Retail – Think Outside the Store
Retail has broken free from brick-and-mortar establishments and catalog shopping to include social media, online and [...]

[Read more →]

Tags:·················

Vacation Series: Organization

August 17th, 2010 · No Comments · Opinion

Image courtesy of The Container Store
By Kimberly Reyes (@CommDuCoeur)
It’s August, and while some of you are probably cruising down the French Riviera (jealous!), some of us are getting blasted with air conditioning as we pound away at our keyboards trying to get our ducks in a row before the busy fall season.  That’s why all [...]

[Read more →]

Tags:·······

Vacation Series: Networking

August 16th, 2010 · No Comments · Opinion

By Sven Larsen (@zemoga)
August means vacation – especially in the global world of pharma, many of our colleagues and clients are in Europe, where August holidays are even more common. But if a tight budget means you’re finding yourself on the clock while your colleagues and clients are on holiday, we’ve got [...]

[Read more →]

Tags:·······

A Multifaceted Strategy

August 13th, 2010 · No Comments · Opinion

By Andy Smith
Social media has changed many facets of business from how we interact, exchange ideas and information, and generate innovation. Even traditional media is going social to engage audiences. However, it’s important to remember that networking, educating and raising awareness among your target audience needs to happen beyond the digital frontier. While everyone seems [...]

[Read more →]

Tags:·················

New Jobs in Pharma: Interactive New Media Social Web Guru

July 13th, 2010 · 4 Comments · Opinion

By Sven Larsen (@zemoga)
Which came first – the Pixel or the Pill? That’s what we’re often asked when people talk to us about our media and marketing efforts. Of course, the real question they’re often asking us is “Do you guys know anything about Pharma or are you just winging it?”
Luckily for us, we can [...]

[Read more →]

Tags:········

The Six A’s for Managing Legal Disputes

June 11th, 2010 · 8 Comments · Knowledge, Opinion

Kristie Kuhl, JD, Senior Vice President, Makovsky + Co is a counselor on issues that impact biotechnology, specialty pharma, health-product distribution and medical devices.   She led issues management teams assisting US-based B. Braun in response to hospital-related crises. Kristie also led the Agency team that launched Alexion’s Soliris, [...]

[Read more →]

Tags:·········

Pixels & Pills is a Dosie Awards Finalist!

April 7th, 2010 · 1 Comment · News

9 categories.  500 contestants.  1,600 votes.  1 epic battle.
Thanks so much to everyone who voted for Pixels & Pills in the Best Industry Observer blog.  After an intense week, we’re so happy to announce that your support landed us a finalist spot in the Dose of Digital Dosie Awards!
As we share our knowledge and insight [...]

[Read more →]

Tags:·······

Show Pixels & Pills Some Love at the Dosie Awards!

April 2nd, 2010 · 4 Comments · News

When former AstraZeneca sales executive Jonathan Richman launched Dose of Digital, he embarked on a mission to enhance the patient experience and safety by helping Pharma companies adopt digital technologies in a strategic way.  Through Richman’s thought leadership and the blog’s various services (including a Social Media Wiki that catalogues “ones to watch” in the [...]

[Read more →]

Tags:······

Sharing a Shower: How Consumers Become Brand Advocates

March 25th, 2010 · 4 Comments · Opinion

By Mike Myers (@mmyerspalio)
Have you ever received an e-mail like this one?
I may have had a few in the past, but was still surprised to find a friend of mine spreading their enthusiasm so boldly. If I didn’t know better, I’d guess he had some sort of affiliation with the company.
Frankly, I’m jealous of the [...]

[Read more →]

Tags:············

The Woes of R&D

March 9th, 2010 · 1 Comment · Knowledge, Opinion

By Russ Ward (@russcward)
The most recent McKinsey Quarterly offered a report called “The Road to Positive R&D Returns.” Essentially, it said that traditional small molecules are no longer a viable business plan for pharma companies, and that they can’t hang their hats on biologics either, because they’re running into many the same issues with development [...]

[Read more →]

Tags:······